Perioperative Anemia in the Elderly

Clinics in Geriatric Medicine

Volumn 24, Issue 4, 2008, Pages 641-648

  Kumar, Ajay ^a   Carson, Jeffrey L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Anemia; Management of anemia; Perioperative Anemia; Surgery in elderly

Indexed keywords

HEMOGLOBIN;

ANEMIA; BLOOD TRANSFUSION; ELECTIVE SURGERY; ERYTHROCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; LENGTH OF STAY; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; REVIEW;

AGED; ANEMIA; HUMANS; PREOPERATIVE CARE;

EID: 54549092108     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2008.07.003     Document Type: Review

References (38)

1. Blanc B. Nutritional anaemias. Report of a WHO Scientific Group. In: Hallberg L, Finch CA, editors. WHO Tech Rep Se 1968;405:1-40.
2. Shander A., Knight K., Thurer R., et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 116 Suppl 7A (2004) 58S-69S
3. Carson J.L., Duff A., Berlin J.A., et al. Perioperative blood transfusion and postoperative mortality. JAMA 279 3 (1998) 199-205
4. Carson J.L., Duff A., Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 348 9034 (1996) 1055-1060
5. Wu W.C., Schifftner T.L., Henderson W.G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297 22 (2007) 2481-2488
6. Goodnough L.T., Shander A., Spivak J.L., et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesth Analg 101 6 (2005) 1858-1861
7. Dunne J.R., Malone D., Tracy J.K., et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res 102 2 (2002) 237-244
8. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 10 (2005) 1011-1023
9. Krantz S.B. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci 307 5 (1994) 353-359
10. Theusinger O.M., Leyvraz P.F., Schanz U., et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 107 6 (2007) 923-927
11. Bezwada H.P., Nazarian D.G., Henry D.H., et al. Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J Bone Joint Surg Am 85-A 9 (2003) 1795-1800
12. Feagan B.G., Wong C.J., Kirkley A., et al. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 133 11 (2000) 845-854
13. Goldberg M.A., McCutchen J.W., Jove M., et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25 8 (1996) 544-552
14. Heiss M.M., Tarabichi A., Delanoff C., et al. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study. Surgery 119 5 (1996) 523-527
15. Weber E.W., Slappendel R., Hemon Y., et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 22 4 (2005) 249-257
16. Drueke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 20 (2006) 2071-2084
17. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 20 (2006) 2085-2098
18. Bennett C.L., Silver S.M., Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 299 8 (2008) 914-924
19. Corwin H.L., Gettinger A., Fabian T.C., et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 357 10 (2007) 965-976
20. Waters J.H., Biscotti C., Potter P.S., et al. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 92 6 (2000) 1531-1536
21. Goodnough L.T., Monk T.G., Sicard G., et al. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: an analysis of cost and benefit. J Vasc Surg 24 2 (1996) 213-218
22. Monk T.G., Goodnough L.T., Brecher M.E., et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 91 1 (1999) 24-33
23. Monk T.G., and Goodnough L.T. Acute normovolemic hemodilution. Clin Orthop Relat Res 357 (1998) 74-81
24. Bryson G.L., Laupacis A., and Wells G.A. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 86 1 (1998) 9-15
25. Matot I., Scheinin O., Jurim O., et al. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 97 4 (2002) 794-800
26. Olsfanger D., Fredman B., Goldstein B., et al. Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement. Br J Anaesth 79 3 (1997) 317-321
27. Wong J.C., Torella F., Haynes S.L., et al. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Ann Surg 235 1 (2002) 145-151
28. Segal J.B., Blasco-Colmenares E., Norris E.J., et al. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 44 5 (2004) 632-644
29. Schmied H., Kurz A., Sessler D.I., et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 347 8997 (1996) 289-292
30. Valeri C.R., Feingold H., Cassidy G., et al. Hypothermia-induced reversible platelet dysfunction. Ann Surg 205 2 (1987) 175-181
31. Rohrer M.J., and Natale A.M. Effect of hypothermia on the coagulation cascade. Crit Care Med 20 10 (1992) 1402-1405
32. Scher K.S., and Coil Jr. J.A. Effects of oxidized cellulose and microfibrillar collagen on infection. Surgery 91 3 (1982) 301-304
33. Taylor Jr. L.M., Mueller-Velten G., Koslow A., et al. Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts. J Vasc Surg 38 4 (2003) 766-771
34. Hebert P.C., Wells G., Tweeddale M., et al. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 155 5 (1997) 1618-1623
35. Carson J.L., Terrin M.L., Magaziner J., et al. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion 46 12 (2006) 2192-2206
36. Klein H.G., Spahn D.R., and Carson J.L. Red blood cell transfusion in clinical practice. Lancet 370 9585 (2007) 415-426
37. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 12 (2008) 1229-1239
38. Practice Guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84 3 (1996) 732-747